266 related articles for article (PubMed ID: 28120592)
1. Profile of People Who Inject Drugs in Tehran, Iran.
Amin-Esmaeili M; Rahimi-Movaghar A; Gholamrezaei M; Razaghi EM
Acta Med Iran; 2016 Dec; 54(12):793-805. PubMed ID: 28120592
[TBL] [Abstract][Full Text] [Related]
2. Comparing Injecting Risk Behaviors of Long-Term Injectors with New Injectors in Tehran, Iran.
Bazrafshan MR; Noroozi M; Ghisvand H; Noroozi A; Alibeigi N; Abbasi M; Higgs P; Armoon B
Subst Use Misuse; 2019; 54(2):185-190. PubMed ID: 30474470
[TBL] [Abstract][Full Text] [Related]
3. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
[TBL] [Abstract][Full Text] [Related]
4. Transition to injection amongst opioid users in Iran: implications for harm reduction.
Malekinejad M; Vazirian M
Int J Drug Policy; 2012 Jul; 23(4):333-7. PubMed ID: 21996166
[TBL] [Abstract][Full Text] [Related]
5. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
6. HIV risk behavior among injection drug users in Tehran, Iran.
Razani N; Mohraz M; Kheirandish P; Malekinejad M; Malekafzali H; Mokri A; McFarland W; Rutherford G
Addiction; 2007 Sep; 102(9):1472-82. PubMed ID: 17645427
[TBL] [Abstract][Full Text] [Related]
7. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
8. Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran.
Khezri M; Tavakoli F; Karamouzian M; Sharifi H; Ghalehkhani N; Mousavian G; Mehmandoost S; Bazargani M; Hosseinpour AM; Mahboubi M; Baral S; Shokoohi M
J Subst Abuse Treat; 2022 Dec; 143():108868. PubMed ID: 36137306
[TBL] [Abstract][Full Text] [Related]
9. Operating needle exchange programmes in the hills of Thailand.
Gray J
AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
[TBL] [Abstract][Full Text] [Related]
10. Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention.
Mateu-Gelabert P; Harris S; Berbesi D; Segura Cardona ÁM; Montoya Vélez LP; Mejía Motta IE; Jessell L; Guarino H; Friedman SR
Subst Use Misuse; 2016 Jan; 51(2):230-40. PubMed ID: 26800352
[TBL] [Abstract][Full Text] [Related]
11. Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar.
O'Keefe D; Aung SM; Pasricha N; Wun T; Linn SK; Lin N; Aitken C; Hughes C; Dietze P
Int J Drug Policy; 2018 Aug; 58():22-30. PubMed ID: 29754104
[TBL] [Abstract][Full Text] [Related]
12. HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.
Gangi MF; Karamouzian M; Nedjat S; Rahimi-Movaghar A; Yazdani K; Shokoohi M; Mirzazadeh A
Int J Drug Policy; 2020 Oct; 84():102868. PubMed ID: 32717706
[TBL] [Abstract][Full Text] [Related]
13. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system.
Mojtahedzadeh V; Razani N; Malekinejad M; Vazirian M; Shoaee S; Saberi Zafarghandi MB; Hernandez AL; Mandel JS
AIDS Behav; 2008 Jul; 12(4 Suppl):S7-12. PubMed ID: 18521737
[TBL] [Abstract][Full Text] [Related]
14. The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland.
Dunleavy K; Hutchinson SJ; Palmateer N; Goldberg D; Taylor A; Munro A; Shepherd SJ; Gunson RN; Given S; Campbell J; McAuley A
Int J Drug Policy; 2021 Dec; 98():103369. PubMed ID: 34340168
[TBL] [Abstract][Full Text] [Related]
15. Sharing of Needles and Syringes among Men Who Inject Drugs: HIV Risk in Northwest Bangladesh.
Pasa MK; Alom KR; Bashri Z; Vermund SH
PLoS One; 2016; 11(2):e0148276. PubMed ID: 26848756
[TBL] [Abstract][Full Text] [Related]
16. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
17. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
Kim NJ; Jin H; McFarland W; Raymond HF
Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs.
Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF
Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143
[TBL] [Abstract][Full Text] [Related]
19. Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark.
Kinnard EN; Howe CJ; Kerr T; Skjødt Hass V; Marshall BD
Harm Reduct J; 2014 Oct; 11(1):29. PubMed ID: 25352296
[TBL] [Abstract][Full Text] [Related]
20. Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits.
Folch C; Lorente N; Majó X; Parés-Badell O; Roca X; Brugal T; Roux P; Carrieri P; Colom J; Casabona J;
Int J Drug Policy; 2018 Dec; 62():24-29. PubMed ID: 30352331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
